Category: Cancer Treatment
Cancer Treatment market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Gastric Cancer Monoclonal Antibodies (mAb)
The 2025-2030 World Outlook for Gastric Cancer Monoclonal Antibodies (mAb) This study covers the world outlook for gastric cancer monoclonal antibodies (mAb) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo ... Read More
-
The 2025-2030 World Outlook for Melanoma Scanners
The 2025-2030 World Outlook for Melanoma Scanners This study covers the world outlook for melanoma scanners across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More
-
The 2025-2030 World Outlook for Thyroid Cancer Drugs
The 2025-2030 World Outlook for Thyroid Cancer Drugs This study covers the world outlook for thyroid cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More
-
The 2025-2030 World Outlook for Progestogens for Cancer Cachexia
The 2025-2030 World Outlook for Progestogens for Cancer Cachexia This study covers the world outlook for progestogens for cancer cachexia across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in que ... Read More
-
The 2025-2030 World Outlook for Trastuzumab
The 2025-2030 World Outlook for Trastuzumab This study covers the world outlook for trastuzumab across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the p ... Read More
-
The 2025-2030 World Outlook for Bladder Cancer Therapeutics
The 2025-2030 World Outlook for Bladder Cancer Therapeutics This study covers the world outlook for bladder cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More
-
The 2025-2030 World Outlook for Multiple Myeloma Therapeutics
The 2025-2030 World Outlook for Multiple Myeloma Therapeutics This study covers the world outlook for multiple myeloma therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More
-
The 2025-2030 World Outlook for Cervical Cancer Diagnostics
The 2025-2030 World Outlook for Cervical Cancer Diagnostics This study covers the world outlook for cervical cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More
-
The 2025-2030 World Outlook for Cervical Cancer Drugs and Diagnostics
The 2025-2030 World Outlook for Cervical Cancer Drugs and Diagnostics This study covers the world outlook for cervical cancer drugs and diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the coun ... Read More
-
The 2025-2030 World Outlook for Antiemetic Chemotherapy Drugs
The 2025-2030 World Outlook for Antiemetic Chemotherapy Drugs This study covers the world outlook for antiemetic chemotherapy drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More
-
The 2025-2030 World Outlook for Triple-Negative Breast Cancer Treatments
The 2025-2030 World Outlook for Triple-Negative Breast Cancer Treatments This study covers the world outlook for triple-negative breast cancer treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for th ... Read More
-
The 2025-2030 World Outlook for Colorectal Cancer Therapeutics
The 2025-2030 World Outlook for Colorectal Cancer Therapeutics This study covers the world outlook for colorectal cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More
-
The 2025-2030 World Outlook for Liquid Lung Biopsies
The 2025-2030 World Outlook for Liquid Lung Biopsies This study covers the world outlook for liquid lung biopsies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More
-
The 2025-2030 World Outlook for Cancer Therapies
The 2025-2030 World Outlook for Cancer Therapies This study covers the world outlook for cancer therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More
-
The 2025-2030 World Outlook for Cancer Tumor Profiling
The 2025-2030 World Outlook for Cancer Tumor Profiling This study covers the world outlook for cancer tumor profiling across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for Carcinoembryonic Antigen
The 2025-2030 World Outlook for Carcinoembryonic Antigen This study covers the world outlook for carcinoembryonic antigen across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2025-2030 World Outlook for Oncolytic Virus Immunotherapies
The 2025-2030 World Outlook for Oncolytic Virus Immunotherapies This study covers the world outlook for oncolytic virus immunotherapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2025-2030 World Outlook for Neuroendocrine Carcinoma
The 2025-2030 World Outlook for Neuroendocrine Carcinoma This study covers the world outlook for neuroendocrine carcinoma across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2025-2030 World Outlook for Immunotherapy Cancer Drugs
The 2025-2030 World Outlook for Immunotherapy Cancer Drugs This study covers the world outlook for immunotherapy cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
-
The 2025-2030 World Outlook for Colerectal Cancers
The 2025-2030 World Outlook for Colerectal Cancers This study covers the world outlook for colerectal cancers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More
-
The 2025-2030 World Outlook for Patient Derived Xenograft-PDX Mouse Models
The 2025-2030 World Outlook for Patient Derived Xenograft-PDX Mouse Models This study covers the world outlook for patient derived xenograft-PDX mouse models across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo ... Read More
-
The 2025-2030 World Outlook for Kidney Cancer Drugs
The 2025-2030 World Outlook for Kidney Cancer Drugs This study covers the world outlook for kidney cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Cancer Supportive Care Therapeutics
The 2025-2030 World Outlook for Cancer Supportive Care Therapeutics This study covers the world outlook for cancer supportive care therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More
-
The 2025-2030 World Outlook for Basal Cell Carcinoma Treatments
The 2025-2030 World Outlook for Basal Cell Carcinoma Treatments This study covers the world outlook for basal cell carcinoma treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2025-2030 World Outlook for Checkpoint Inhibitors
The 2025-2030 World Outlook for Checkpoint Inhibitors This study covers the world outlook for checkpoint inhibitors across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
Research Assistance
